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Abstract 
Purpose: The purpose of this pilot study was to describe parents’ perceived healthcare provider support for integrating technology, 
satisfaction with insulin pump use in their child with T1DM, and the relationship between parents’ perceived healthcare provider 
support and satisfaction with insulin pump use.   
Methods: A cross-sectional, correlational design was used to collect data for the present study. The study was conducted through an 
Internet survey among Mid-South parents who have a child with T1DM, 18 years old or younger using an insulin pump and/or 
continuous glucose monitoring (CGM).  Frequencies, descriptive statistics, and correlation coefficients were calculated.  
Results: Most of the parents surveyed used an endocrinologist/pediatric endocrinologist as their primary diabetes healthcare 
provider and considered three to four healthcare professionals as part of the diabetes healthcare team who helped them utilize 
insulin pumps and advanced technologies.  Parents (23.4%) indicated a pharmacist was part of the healthcare team who helped them 
utilize technology.  Parents appeared to perceive support for using insulin pumps; however, there is room for improvement.  The 
more perceived support for integrating technology, the more satisfied the parents were with using insulin pumps (r=0.431, p=0.005). 
Conclusions: Results from this study suggest that parents and children need continued education, support and training to integrate 
insulin pumps into diabetes self-management.  As more patients attempt to adopt insulin pumps and other advanced technologies, it 
will be important for pharmacists to support the adoption and integration of these technologies and be knowledgeable and helpful if 
asked about technology-related challenges. 
 
 
Purpose 
Although continuous subcutaneous insulin infusion (CSII), 
more commonly known as insulin pump therapy, has been 
shown to improve blood glucose control, its use is not widely 
adopted.1,2,3  Insulin pump therapy use is associated with high 
household incomes, having private healthcare insurance, a  
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higher level of parental education, as well as being 
Caucasian.4  Discontinuation rates are estimated to range 
from 0 - 64% in children and adults.5  Reasons for 
discontinuation found in clinical studies include skin 
discomfort, infection at infusion site, anxiety about 
technology, body image concerns, cost/insurance issues, 
technical difficulties with pump, inconvenience, and dislike or 
difficultly with needle insertion.5  Few studies have looked at 
child and parent experiences with insulin pumps in the real 
world.   
 
Another newer diabetes technology to help improve glucose 
control is Continuous Glucose Monitoring (CGM).6,7  Likewise, 
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this technology is also not widely adopted in the pediatric 
population.  The Juvenile Diabetes Research Foundation 
(JDRF) Continuous Glucose Monitoring Study Group stated 
that while studies suggest promise for CGM, “questions 
remain regarding the potential effects of its incorporation 
into diabetes management on psychosocial and patient-
reported outcomes.  The extent to which CGM exerts positive 
or negative psychosocial effects could influence patients’ 
frequency and persistence of CGM use.”8  
 
As use of technology is associated with improved glucose 
control, clinicians will need to find ways to educate parents 
and children to overcome barriers and set realistic 
expectations to promote its use in children with Type 1 
Diabetes Mellitus (T1DM).  It has been suggested that 
increased provider support, education, and monitoring will be 
necessary to improve the adoption and utilization of insulin 
pumps and other technologies in diabetes self-management.5  
It is likely that relationships with healthcare providers can 
facilitate the integration of insulin pumps into diabetes self-
management in juvenile patients with T1DM.9  Thus, it is 
suggested that an important factor in the adoption and 
continued use of insulin pumps is perceived healthcare 
provider support for integrating technology. Perceived 
healthcare provider support is defined as the extent to which 
the parent perceives that the healthcare team acknowledges 
and supports the use of technology in the child’s diabetes 
self-management.  This definition is adapted from Ludman’s 
(2002) work on perceived clinical support in the mental 
illnesses.10  This concept of provider support is related to the 
more general construct of a therapeutic relationship, yet it 
focuses specifically on the perception of feeling supported by 
healthcare providers in using technology in diabetes self-
management.  
 
Studies have shown that community pharmacists can have a 
positive impact on patient outcomes in diabetes patients.11  
As insulin pump use increases, non-specialty practitioners will 
need to be knowledgeable of diabetes technology.  The 
pharmacy is a point of access for diabetes medications and 
supplies, and thus the pharmacist will be key in educating 
patients and supporting the use of insulin pumps and CGM.1  
Potti and Haines (2009) state that pharmacists should be 
familiar with the newer technology and help patients 
troubleshoot problems with their use.12    
 
Additional research is needed to better understand how 
healthcare providers, including pharmacists, can influence the 
use and satisfaction of insulin pumps in diabetes self-
management in the real world.  Thus, the purpose of this pilot 
study was to describe parents’ perceived healthcare provider 
support for integrating technology, satisfaction with insulin 
pumps in the diabetes self-management of their child with 
T1DM, and the relationship between parents’ perceived 
healthcare provider support and satisfaction with insulin 
pump use in their children.  It is hypothesized that parents 
who perceive more support would be more satisfied with the 
insulin pump.  
 
Methods 
Study Design 
A cross-sectional, correlational design was used to collect 
data for the present study. The study was approved by the 
Institutional Review Board (IRB) at a southeastern university 
under exempt status.  This article presents the methods and 
results of one portion of a larger survey study.  
 
Sample and Data Collection Procedures 
Mid-South parents who have a child with T1DM, 18 years old 
or younger using an insulin pump or CGM were surveyed.  
The Northwestern Arkansas, West Tennessee, and Mississippi 
chapters of the JDRF sent an e-mail with the survey link to 
their membership.  A follow-up reminder e-mail was sent one 
week later.  The Nashville JDRF chapter placed a link to the 
survey on their Facebook page.  Camp Hopewell, which offers 
a summer camp specifically for children with TIDM, also sent 
the survey to parents in their database who have children 
with T1DM.  The invite e-mail provided information about the 
purpose of the study and that the study was voluntary and 
anonymous.  To ensure the appropriate participants (i.e., 
parents who had a child with T1DM, 18 years old or younger) 
responded to the survey, several screening questions were 
included in the beginning of the survey.   
 
Survey Instrument 
The electronic survey was developed using Qualtrics®.  
Screening questions asked the potential participant if he/she 
had a child with T1DM who is currently 18 years old or 
younger and if their child was currently using an insulin pump 
and/or CGM.  
 
The first part of the survey included demographic and health 
status variables about the parent respondent and their child 
with T1DM.  The next part of the survey included questions 
about which members of the healthcare team helped 
integrate technology into the child’s diabetes self-
management and what information resources they used to 
learn about advanced technology.  This section of the survey 
also included 9 items to measure perceived healthcare 
provider support for integrating technology into diabetes self-
management.  As previously stated, perceived healthcare 
provider support was defined as the extent to which the 
parent perceives that the healthcare team acknowledges and 
supports the use of technology in the child’s diabetes self-
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management. This measure was adapted from the Healthcare 
Climate Questionnaire, which is an instrument that measures 
provider support (i.e., the extent to which healthcare 
providers acknowledge and support patients’ self-
management of their chronic illness).  This measure has been 
used in patients with mental health disorders and had a 
Cronbach’s alpha of 0.95.13  
 
Further, the survey included questions about the parent’s and 
child’s experiences with insulin pumps (e.g., number of years 
using the pump, number of pumps used, etc.) and insulin 
pump satisfaction.  For this study, insulin pump satisfaction 
was defined as the parent’s report of face-valid and salient 
aspects of the process and outcome of the insulin pump use.2  
It was measured using the Insulin Pump Therapy Satisfaction 
questionnaire.2  This questionnaire is a standardized measure 
of satisfaction with insulin pumps that includes four items 
related to the process (satisfaction, preparedness, ease of 
use, and ease of use relative to expectations) and six 
additional items that assess the outcome (i.e., perceived 
effectiveness) of the use of the insulin pump. The first four 
items are rated on a 5-point Likert-type scale, with the end 
points reflecting the item (very unsatisfied to very satisfied, 
very unprepared to very prepared, not at all easy to very 
easy, and much harder to much easier).  Higher numbers on 
the scale indicate greater satisfaction with insulin pumps. The 
six additional items are related to key areas of life change 
associated with using the pump.  They are also rated on a 5-
point Likert-type scale ranging from 1=much worse to 
5=much better.  In a previous study, these 10 items had 
acceptable reliability with a Cronbach’s alpha of 0.69.2  To 
assess the barriers to insulin pump use, a question with 
several barriers identified from the literature was included 
whereby parents selected the most common barriers to 
continued use. 
 
The survey was professionally examined by three diabetes 
experts, and their comments were used to make revisions in 
the survey content.  Further, the instrument was pre-tested 
by administering it to three parents at a diabetes clinic to 
determine the approximate time needed to complete the 
entire questionnaire, as well as for wording, and item clarity.  
Based on the feedback from the pre-test, the instrument was 
revised before administering it to participating parents.   
 
Data Analysis 
Once the survey was closed, data were transferred from 
Qualtrics® to SPSS 20.0 (Chicago, IL) for analysis.  Data were 
reviewed for missing data and responses with missing data 
for more than 50% of the eligible items were deleted from 
the analysis file.  Frequencies, descriptive statistics, and 
correlation coefficients were calculated.    
Results 
In this pilot study, 98 parents responded to the survey, of 
which 66 indicated that they had a child 18 years old or 
younger with TIDM.  From the 66 responses, 48 parents 
indicated that their child currently uses advanced diabetes 
technology, while 18 parents indicated that their child does 
not.  One parent of the 48 parent responses only provided 
demographic information in the survey and was therefore 
excluded.  Thus, the survey produced 47 final responses from 
parents of children with TIDM who are currently utilizing an 
insulin pump and/or CGM device. The eighteen parents 
whose children did not use insulin pumps and/or CGM 
devices cited cost issues (33%) and the potential for 
interference with sports/outside play/other activities (22.2%) 
as the two most common reasons for not using advanced 
diabetes technology.   
 
Forty-three of the 47 participants were white, 63.8% lived in 
an urban community, 76.6% had a college degree or higher 
and 96% had private insurance.  Sixty-four percent of the 
respondents had a male child with diabetes.  The child’s 
mean age was 13.87 years (range 6-18 years), and the mean 
age when diagnosed with T1DM was 8.09 years.  Sixty-two 
percent of respondents indicated that their child’s A1C at last 
visit was < 8.0%, 23.4% indicated it was between 8.0 – 9.0%, 
while 14.9% of the parents responded that their child’s A1C 
was above 9.0%.  These sample characteristics are similar to 
what we have found in another study of children with Type 1 
diabetes and to other studies in the literature based on this 
region of the country. 
 
Participants most frequently considered their pediatric 
endocrinologist/endocrinologist (80.9%) and certified 
diabetes educator (CDE) (57.4%) to be part of their child’s 
diabetes healthcare team who helped integrate diabetes 
technology into their child’s diabetes self-management.  
Participants reported that on average they had 3.83 members 
on their healthcare team who helped them integrate 
technology into their child’s diabetes self-management, 
including diabetes technology company representatives, 
other physicians, nurses, pharmacists, or dieticians (Table 1).  
When asked to select which information sources they used to 
get information about their insulin pumps or CGM, the top 
three sources were: endocrinologist (52.2%), support group 
(51.1%), and diabetes technology company representative 
(46.8%).  Three participants indicated the pharmacist was a 
source of information about insulin pumps or CGM.   
 
Perceived diabetes healthcare team support specifically 
pertaining to integrating technology into the child’s diabetes 
self-management was measured using nine items (Table 2).  
Cronbach’s alpha was calculated to be 0.98, similar to the 
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Perron et al. results.13  The overall mean score for the nine 
items was 5.97 (range = 1.78 to 7.00, overall summated score 
= 53.71), indicating support with room for improvement. 
 
Forty-two parents indicated that their child is currently using 
an insulin pump in their diabetes self-management.  Of the 42 
respondents, 62.8% have used their current insulin pump for 
more than two years, and 18.6% have used more than three 
different insulin pumps.  The majority of respondents 
indicated that either the diabetes technology company 
representative (41.9%) or a CDE (39.5%) initially trained them 
on the use of the insulin pump technology.   
 
Ten items were used to measure satisfaction with insulin 
pumps, where a higher number indicated a more positive 
response (Table 3).  To assess reliability, Cronbach’s alpha 
was calculated.  The alpha value was 0.82, which is 
acceptable.  When the results were scaled from one to five, 
the average satisfaction sum was 4.08.  For the process items, 
parents indicated that it was not very easy to use and that it 
was more difficult to use compared to what was expected.  
For the outcome items, parents agreed that the insulin pump 
improved flexibility of meal and sleep schedule and food 
variety.  When provided with a list of sixteen common 
barriers to using insulin pumps, study participants reported 
infusion site rotation issues (57.4%), cost and insurance issues 
related to insulin pump supplies (52.2%), infusion site being 
uncomfortable/painful (44.0%), and fear of device 
malfunction (40.4%) as the top four challenges they have 
experienced.  
 
To explore if the perceived diabetes healthcare team support 
was related to satisfaction with insulin pump, a correlation 
coefficient was calculated and found significant (correlation 
coefficient r=0.431; p = 0.005).  Therefore, the greater the 
perceived diabetes healthcare team support, the more 
satisfied the parent of a child with TIDM is with the insulin 
pump. 
 
Discussion 
Diabetes is a multi-faceted disease. For parents of a child with 
diabetes, healthcare provider support is essential in adopting, 
utilizing, and integrating new diabetes technology.  The goal 
of diabetes technology integration is to improve a child’s 
healthcare outcomes and give the parents more control of 
their child’s diabetes management.  It is essential to 
understand how healthcare providers can support the 
integration of advanced technology into diabetes self-
management.  
 
Due to the multitude of health effects that result from 
diabetes, the development of a healthcare team is essential 
to achieving diabetes goals.  Survey participants had a variety 
of different individuals on their healthcare team, including 
pharmacists.  Almost 25% indicated the pharmacist was a key 
member of the team for integrating technology; and it is 
possible that some of the CDEs could be pharmacists as well.  
Pharmacists have an important role to play in helping parents 
and children utilize insulin pumps and CGMs.  There are 
opportunities for more community pharmacists to develop 
services to help diabetes patients use insulin pumps and 
other advanced technologies.    
 
The participants appeared to perceive support for integrating 
technology; however, there is room for improvement.  For 
example, parents rated the items related to technology 
training, awareness of what to expect from technology, and 
encouragement to ask questions about technology lower 
than some of the other items.  Even these adopters of 
technology still perceive barriers to using the technology and 
dealing with some of the economic and psychosocial issues 
resulting from the use of technology.  The use of an insulin 
pump did not alleviate worry related to diabetes and may 
have increased the social aspect of device usage.  More 
support may be necessary to combat the psychosocial issues 
related to technology integration.  By addressing some of the 
psychosocial aspects of technology integration, it may 
possible to increase satisfaction and adoption of technology 
in juvenile diabetes management.  
 
As more patients attempt to adopt advanced technologies, it 
will be important for the entire diabetes healthcare team to 
support the adoption and integration of these technologies.  
Some healthcare professionals, including pharmacists or 
dieticians, may be underutilized with respect to integrating 
technology into diabetes self-management.  The results 
emphasize the need for pharmacists to be trained and 
confident with insulin pumps and other advanced 
technologies.   The participants did not utilize the pharmacist 
as an information source about technology.  It is essential 
that pharmacists are not only educated about diabetes 
technology but also make their skills accessible to patients 
when and if questions and concerns arise.  
 
More insulin pump education and training for pharmacists 
providing diabetes care may be needed.12 There will be an 
increased need for pharmacists to develop niche services 
around diabetes technology and to become certified insulin 
pump trainers. These pharmacists will be important in 
training patients on how to use the technology, trouble-
shooting when the technology malfunctions, and helping the 
patient adapt to the use of technology.   
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Results from this study suggest that parents and children 
need continued support and training to integrate technology 
into diabetes self-management. These parents were not 
participating in other clinical trials so these results reflect 
adopting technology in the real-world, particularly in the 
South.  Further investigation is needed to better understand 
the clinical, economic, and psychosocial aspects of 
technology integration as well as methods to increase 
perceived support from pharmacists for adopting diabetes 
technology.  
 
Certain limitations of this survey study need to be 
acknowledged. The study employed a convenience sampling 
technique in a geographically select area and thus the 
perceptions of parent respondents that participated in the 
study may not be representative of all parents of children 
with T1DM. Additionally, the limited sample size restricts the 
generalizability of the findings from this study. However, the 
study still highlights the importance of healthcare 
professionals, including pharmacists, in educating and 
facilitating the use of insulin pumps and other technologies. 
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Tables 
 
Table 1: Members of Healthcare Team Who Help Integrate Technology into Child’s Diabetes Self-Management 
Healthcare Team Members Frequency of Healthcare Team Member 
Utilization N (%) 
Pediatric Endocrinologist/Endocrinologist 38 (80.9%) 
Certified Diabetes Educator (CDE) 27 (57.4%) 
Diabetes Technology Company Representative 23 (48.9%) 
Nurse/ Nurse Practitioner 19 (40.4%) 
Pediatrician/Other Family Doctor 16 (34%) 
Diabetic Supplier 11 (23.4%) 
Pharmacist 11 (23.4%) 
Dietician 9 (19.1%) 
Board Certified – Advanced Diabetes Manager (BC-ADM) 4 (8.5%) 
  
 
 
 
 
Table 2: Mean Item Scores for Perceived Diabetes Healthcare Team Support 
Item Mean Score* 
My child’s diabetes healthcare team conveys confidence in my ability to make 
change with advanced diabetes technology. 
6.26 
I feel understood by my child’s diabetes healthcare team. 6.14 
My child’s diabetes healthcare team regularly reviews my child’s progress 
while using advanced diabetes technology. 
6.00 
I feel that my child’s diabetes healthcare team has provided me choices and 
options with advanced diabetes technology. 
5.95 
My child’s diabetes healthcare team encourages me to ask questions about 
advanced diabetes technology. 
5.93 
My child’s diabetes healthcare team makes sure we stay in regular contact.  5.88 
My child’s diabetes healthcare team made me aware of what to expect from 
using advanced diabetes technology. 
5.88 
My child’s diabetes healthcare team tries to understand how I see things 
before suggesting a new way of doing things with advanced diabetes 
technology. 
5.86 
My child’s diabetes healthcare team has provided training on advanced 
diabetes technology. 
5.81 
Overall Mean Score: 
Overall Summated Score: 
5.97 
53.71 
*7-point scale where 1 = Strongly disagree and 7 = Strongly agree 
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Table 3: Satisfaction with Insulin Pump 
Item Mean Score* 
Preparedness for transition to insulin pump 4.05 
Satisfaction with insulin pump 3.95 
Ease of use of insulin pump 3.91 
Difficulty of insulin pump use compared to expectation 3.51 
Flexibility of meal schedule 4.60 
Food variety 4.49 
Flexibility of sleep schedule 4.47 
Knowledge of diabetes 4.09 
Level of your child’s responsibility 3.88 
Worry related to diabetes 3.81 
Overall Mean Score: 
Overall Summated Score: 
4.08 
40.76 
*Higher scores indicate greater satisfaction on a 5 point Likerty-type scale  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
